0      0

AONN+ Annual 2020


SAT01 - Industry Sponsored Session | Identifying Appropriate Patients for NINLARO® (ixazomib): An Oral Treatment for Patients with Multiple Myeloma (non-CE) Presentation by Takeda


Nov 7, 2020 7:30am ‐ Nov 7, 2020 8:45am

Description

This NINLARO education program is intended to provide you with:

  • An overview of multiple myeloma
  • Highlight evolving treatment strategies
  • Present NINLARO clinical trial data
    • Efficacy
    • Safety
    • Dosing and administration
  • Discuss the expanding role of nurses in the care of multiple myeloma patients
  • Discuss appropriate patients for treatment with the NINLARO regimen

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content